62772-70-7

Basic information

• Product Name: ETHYL 2-METHYL-IMIDAZO[1,2-A]PYRIMIDINE 3-CARBOXYLATE
• Synonyms: Ethyl 2-methylimidazo[1,2-a]pyrimidine-3-carboxylate;Imidazo[1,2-a]pyrimidine-3-carboxylic acid,2-methyl-,ethyl ester
• CAS NO: 62772-70-7
• Molecular Formula: C10H11N3O2
• Molecular Weight: 205.21
• Mol File: 62772-70-7.mol
• Article Data: 6

Chemical Properties

• Appearance: /
• Density: 1.29 g/cm³
• Refractive Index: 1.615
• CAS DataBase Reference: ETHYL 2-METHYL-IMIDAZO[1,2-A]PYRIMIDINE 3-CARBOXYLATE(CAS DataBase Reference)
• NIST Chemistry Reference: ETHYL 2-METHYL-IMIDAZO[1,2-A]PYRIMIDINE 3-CARBOXYLATE(62772-70-7)
• EPA Substance Registry System: ETHYL 2-METHYL-IMIDAZO[1,2-A]PYRIMIDINE 3-CARBOXYLATE(62772-70-7)

Safety Data

• Hazardous Substances Data: 62772-70-7(Hazardous Substances Data)

Usage

General Description

Ethyl 2-methyl-imidazo[1,2-a]pyrimidine 3-carboxylate is a chemical compound with a molecular formula C9H10N4O2. It is a derivative of imidazo[1,2-a]pyrimidine and contains an ethyl ester, a methyl group, and a carboxylate group. ETHYL 2-METHYL-IMIDAZO[1,2-A]PYRIMIDINE 3-CARBOXYLATE has potential pharmacological properties and can be used in the development of pharmaceutical drugs. It may also have relevance in the field of organic synthesis and medicinal chemistry research. It is important to handle and use this chemical with proper care and precautions, as it may pose health hazards if mishandled.

InChI:InChI=1/C10H11N3O2/c1-3-15-9(14)8-7(2)12-10-11-5-4-6-13(8)10/h4-6H,3H2,1-2H3

Upstream product

• 109-12-6 2-aminopyrimidine 
• 609-15-4 ethyl 2-chloro-3-oxo-butyrate 
• 141-97-9 ethyl acetoacetate 
• 84911-18-2 ethyl 2-bromoacetoacetate 

Downstream Products

• 90830-11-8 2-methyl-imidazo[1,2-a]pyrimidine-3-carboxylic acid 

Relevant articles and documents

Research on heterocyclic compounds - Part XXXIX. 2-Methylimidazo[1,2-a]pyrimidine-3-carboxylic derivatives: Synthesis and antiinflammatory activity

The synthesis of a group of 2-methylimidazo[1,2-a]pyrimidine-3-carboxylic esters, acids and amides is described. The structures of new compounds are supported by 1H and 13C NMR spectra. These compounds were tested in vivo for their antiinflammatory analgesic and ulcerogenic activity. Eight new compounds out of fifteen showed remarkable dose-dependent antiinflammatory action in die carrageenan rat paw edema (1/2-1/3 x indomethacin) but weak analgesic activity in the acetic acid writhing test together with negligible ulcerogenic action. The new compounds were found to be lacking in inhibitory activity on cyclooxygenase in vitro.

NBS mediated protocol for the synthesis of N-bridged fused heterocycles in water

A facile and environmental friendly protocol for the synthesis of N-bridged fused bicyclic compounds such as imidazo[1,2-a]pyridines, imidazo[1,2-a]pyrimidines, and imidazo[2,1-b]thiazole, from commercially available starting materials has been developed.

Research on heterocyclic compounds. XVII. 2-Methylimidazo[1,2- a]pyrimidine-3-carboxylic acids

-